Therapy Areas: Cardiovascular
Revier Therapeutics closes EUR6m seed financing and launches operations
26 August 2026 - German pharmaceutical company Revier Therapeutics announced on Tuesday the closing of a EUR6m seed financing and the launch of its operations.The company says that it has established ...
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
24 August 2026 - Medical technology company Tempus AI Inc (NASDAQ: TEM) reported on Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, an AI-ena...
European Commission grants orphan designation for Lundbeck's asedebart
24 August 2026 - Danish biopharmaceutical company H. Lundbeck A/S (CPH: HLUN-B) said on Monday it has received European Commission orphan designation for asedebart (Lu AG13909), its investigational an...
Hanmi Pharm enters exclusive licensing deal with Genentech for obesity therapy HM17321
24 August 2026 - South Korean pharmaceutical company Hanmi Pharm Co Ltd announced on Monday that it has entered into an exclusive licensing agreement with Genentech, a member of the Roche Group (SIX: ...
PTC to acquire BLA-stage ST-920 Fabry disease programme
13 August 2026 - US biopharmaceutical company PTC Therapeutics Inc (NASDAQ:PTCT) announced on Wednesday that it was selected as the winning bidder to acquire ST-920, a BLA-stage, one-time administered...
Olio Labs reveals study demonstrating AI-driven in vivo platform can predict clinical trial outcomes
6 August 2026 - Biotechnology company Olio Labs on Wednesday published research showing that its preclinical in vivo platform predicts human clinical trial outcomes ranging from gastrointestinal adver...